Skip to Content


In the US, Vedolizumab (vedolizumab systemic) is a member of the drug class selective immunosuppressants and is used to treat Crohn's Disease, Crohn's Disease - Maintenance and Ulcerative Colitis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories


Monoclonal antibody

Alpha-4 beta-7 integrin inhibitor

Chemical Name

immunoglobulin G1-kappa, anti-[Homo sapiensalpha4beta7 integrin (lymphocyte Peyer's patch adhesion molecule 1, LPAM-1)], humanized monoclonal antibody; gamma 1 haevy chain (1-451)[humanized VH (Homo sapiensIGHV1-3*01 (84.70%)-(IGHD)IGHJ4*01)[8.8.14](1-121)-Homo sapiensIGHG1*01, CH2 L1.2>A, G1>A(122-451)], (224-219')-disulfide with kappa light chain (1'-219')[humanized V-KAPPA (Homo sapiensIGKV2-29*02 (84.00%)-IGKJ2*01, L124>V)[11.3.9](1'-112')-Homo sapiensIGKC*01 (113'-219')]; (230-230'':233-233'')-bisdisulfide dimer (WHO)

Foreign Names

  • Vedolizumabum (Latin)
  • Vedolizumab (German)
  • V├ędolizumab (French)
  • Vedolizumab (Spanish)

Generic Names

  • Vedolizumab (OS: USAN)
  • UNII-9RV78Q2002 (IS)

Brand Names

  • Entyvio
    Takeda, Australia; Takeda, Bosnia & Herzegowina; Takeda, Brazil; Takeda, Colombia; Takeda, Czech Republic; Takeda, Spain; Takeda, Finland; Takeda, Ireland; Takeda, Lithuania; Takeda, Latvia; Takeda, Norway; Takeda, Peru; Takeda, Poland; Takeda, Serbia; Takeda, Slovakia; Takeda, Thailand; Takeda Belgium, Belgium; Takeda Canada, Canada; Takeda France, France; Takeda Hellas, Greece; Takeda Israel, Israel; Takeda Pharma, Germany; Takeda Pharma, Denmark; Takeda Pharma, Netherlands; Takeda Pharma, Romania; Takeda Pharma, Sweden; Takeda Pharma A/S, Iceland; Takeda Pharma AS, Estonia; Takeda Pharmaceuticals U.S.A, United States; Takeda UK, United Kingdom; Tekeda, Turkey
  • Entyvio 300mg
    Takeda, Hungary; Takeda, Luxembourg; Takeda Pharma, Austria; Takeda Pharma, Switzerland


ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.